← Open Payments lookup

CHRISTINA LAM: Open Payments

NPI 1700171436 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,754 in 236 payments from 19 companies in 2025. Trend: 2023 $4,341 · 2024 $3,257 · 2025 $5,754

Food & beverage: $5,548Education: $206
CompanyPaymentsAmount
Alkermes, Inc.30$807
Neurocrine BioSciences, Inc.28$643
Janssen Pharmaceuticals, Inc11$503
E.R. Squibb & Sons, L.L.C.21$502
Otsuka America Pharmaceutical, Inc.29$491
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$487
Vanda Pharmaceuticals Inc.20$453
Teva Pharmaceuticals USA, Inc.11$419
Axsome Therapeutics, Inc.9$293
ABBVIE INC.18$283

Products named: INGREZZA, REXULTI, COBENFY, CAPLYTA, FANAPT, ARISTADA, INVEGA SUSTENNA, LYBALVI.

Industry payments across CA — which companies pay providers there.